Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease by Seini Moimoi | Jun 11, 2024 | Portfolio News
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC by Seini Moimoi | Jun 6, 2024 | Portfolio News
Nalu PNS System achieves significant and durable pain reduction, meeting the primary endpoint of the COMFORT RCT study by Seini Moimoi | Jun 4, 2024 | Portfolio News
Cohere Health, Medical Mutual, and Rhyme Partner on Utilization Management Transformation by Seini Moimoi | Jun 4, 2024 | Portfolio News
Bolt Medical Announces Results of First 60 Patients in RESTORE ATK Pivotal Trial for the Unique Bolt Intravascular Lithotripsy System by Seini Moimoi | May 29, 2024 | Portfolio News